The platinum-free interval is prognostic but not predictive for lenvatinib plus pembrolizumab, Susana Campos, MD, MPH, told CancerNetwork. Susana M. Campos, MD, MPH, clinical director of the Division ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results